A new chemotype with promise against Trypanosoma cruzi.

Bioorg Med Chem Lett

College of Pharmacy, University of Nebraska Medical Center, 986025 Nebraska Medical Center, Omaha, NE, United States. Electronic address:

Published: January 2020

Pyridyl benzamide 2 is a potent inhibitor of Trypanosoma cruzi, but not other protozoan parasites, and had a selectivity-index of ≥10. The initial structure-activity relationship (SAR) indicates that benzamide and sulfonamide functional groups, and N-methylpiperazine and sterically unhindered 3-pyridyl substructures are required for high activity against T. cruzi. Compound 2 and its active analogs had low to moderate metabolic stabilities in human and mouse liver microsomes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892603PMC
http://dx.doi.org/10.1016/j.bmcl.2019.126778DOI Listing

Publication Analysis

Top Keywords

trypanosoma cruzi
8
chemotype promise
4
promise trypanosoma
4
cruzi pyridyl
4
pyridyl benzamide
4
benzamide potent
4
potent inhibitor
4
inhibitor trypanosoma
4
cruzi protozoan
4
protozoan parasites
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!